Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT03193632 Completed - Clinical trials for Resting Energy Expenditure

Predicting Resting Energy Expenditure in Critically Ill Patients by Measuring Lean Body Mass by US

Start date: July 1, 2017
Phase:
Study type: Observational

The study aims to correlate Lean Body Mass (LBM) Evaluated by Musculoskeletal Ultrasound with Resting Energy Expenditure (REE) measured by Indirect Calorimetry and to generate a predictive equation of REE based on LBM, in addition to identifying other factors that may affect REE such as age, gender, and severity scores.

NCT ID: NCT03188796 Recruiting - Covid19 Clinical Trials

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

VITDALIZE
Start date: October 10, 2017
Phase: Phase 3
Study type: Interventional

In the VITdAL-ICU trial using a large oral dose of vitamin D3 in 480 adult critically ill patients, there was no benefit regarding the primary endpoint hospital length of stay. However, the predefined subgroup with severe vitamin D deficiency (25(OH)D ≤ 12ng/ml) had significantly lower 28-day mortality (36.3% placebo vs. 20.4% vitamin D group, hazard ratio (HR) 0.52 (0.30-0.89), number needed to treat = 6). Therefore, high-dose vitamin D3 in a population of severely vitamin D deficient critically ill patients is a promising and inexpensive intervention that requires confirmatory multicenter studies. To date, only 7 interventions (e.g. noninvasive ventilation or prone positioning) have ever demonstrated mortality benefit for Intensive Care Unit (ICU) patients in multicenter trials. In case of benefit, vitamin D treatment in critically ill patients could be immediately implemented worldwide.

NCT ID: NCT03186716 Completed - Critical Illness Clinical Trials

A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients

Start date: June 11, 2017
Phase: N/A
Study type: Interventional

The effects of colostrum on intestinal permeability in critical ill patients has not been investigated. In current trial, intensive care unit patients with enteral feeding will receive either enteral colostrum or maltodextrin as placebo.

NCT ID: NCT03185962 Completed - Clinical trials for Mechanical Ventilation

Predictors Of Successful Extubation in Critically Ill Patients: Multicentre Observational Study

POSE
Start date: May 1, 2017
Phase:
Study type: Observational

Extubation failure can directly worsen patient outcomes. Therefore, the decision to extubate is a critical moment during an intensive care unit (ICU) stay. The decision to extubate is usually made after a weaning readiness test involving spontaneous breathing on a T-piece or low levels of ventilatory assistance. However, extubation failure still occurs in 10 to 20% of patients. The investigators focused on previously reported physiological risk factors, and were able to obtain from common clinical practice: 1) age, 2) underlying cardiovascular disease, 3) underlying respiratory disease or occurrence of pneumonia, 4) rapid shallow breathing index (RSBI), 5) positive fluid balance during the previous 24 hours, 6) the ratio of arterial oxygen partial pressure to fractional inspired oxygen, 7) Glasgow Coma Scale, 8) respiratory tract secretions. The investigators aimed to assess the incidence and risk factors for extubation failure among critically ill patients who passed the 30 min spontaneous breathing test (SBT) using a low level of pressure support (PS) with positive end-expiratory pressure (PEEP), in a prospective multicenter study.

NCT ID: NCT03182335 Active, not recruiting - Critical Illness Clinical Trials

Vasopressor SAT Study

Start date: April 28, 2014
Phase:
Study type: Observational

To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation.

NCT ID: NCT03178435 Completed - Critical Illness Clinical Trials

Preventing Acute Kidney Injury and Improving Outcome in Critically Ill Patients Utilising Risk Prediction Score

PRAIOC-RISKS
Start date: September 1, 2017
Phase: N/A
Study type: Interventional

An interventional controlled trial to test the feasibility of applying risk score based prevention for critically ill patient at high risk to develop acute kidney injury (AKI)

NCT ID: NCT03176602 Completed - Critical Illness Clinical Trials

Prognostic Value of the SGA and NUTRIC in the ICU

Start date: August 1, 2015
Phase: N/A
Study type: Observational

There are two nutrition assessment tools that are commonly used in the ICU, namely the Subjective Global Assessment (SGA) and Modified Nutrition Risk in Critically Ill Score (mNUTRIC). It has been proposed that both assessments should be performed in the ICU but their combined prognostic ability has not been adequately assessed. This study aimed to: 1) determine the agreement between SGA and mNUTRIC scores, and 2) quantify their utility in discriminating and quantifying hospital mortality risk both independently and in combination.

NCT ID: NCT03175692 Enrolling by invitation - Acute Disease Clinical Trials

Rapid Genetic Diagnosis Employing Next Generation Sequencing for Critical Illness in Infants and Children

Start date: June 14, 2017
Phase: N/A
Study type: Observational

Under the joint efforts of genetic and intensive expert, to establish the high-throughput whole exon sequencing(WES) and analysis all the possible pathogenic genes. To provide patient with the appropriate treatment for genetic disease. Besides, it can identify the genetic factor of idiosyncrasy or susceptibility to explain the medical difficulties and give patients personalized advice.

NCT ID: NCT03170401 Completed - Critical Illness Clinical Trials

Supplemental Enteral Protein in Critical Illness

Start date: November 2016
Phase: Phase 3
Study type: Interventional

The aim of this study is too determine the effect of enteral protein supplementation on biochemical measures of inflammation and protein metabolism in critically ill surgical patients. The investigators will also collect data on important clinical outcomes, including infectious complications, duration of mechanical ventilation and other measures of recovery from critical illness. Hypothesis: That early supplemental protein will increase serum concentrations of transthyretin at three weeks after the onset of illness or injury. Secondarily, the investigators will test whether supplementation, reduces infectious complications and increases ventilator-free days.

NCT ID: NCT03170297 Recruiting - Critical Illness Clinical Trials

SC2i VIPER: EnVenomation Investigation Pilot to Evaluate Recovery

VIPER
Start date: May 5, 2017
Phase:
Study type: Observational

The purpose of this study is to pilot data for a systematic molecular characterization of pathophysiologic perturbations incurred by snake envenomation and compare this to other inflammatory physiologic states such as trauma and sepsis. This sub-study will analyze samples of participants enrolled under the parent study "Surgical Critical Care Initiative Tissue and Data Acquisition Protocol".